Improving quality of submissions
To assist applicants preparing their submissions, the European Medicines Agency (EMA) has published pre-submission checklists for certain procedure types.
These checklists enable applicants to submit high quality applications that avoid frequent mistakes and comply with the legal and regulatory requirements, ensuring submissions can be validated speedily. They are part of the Agency's commitment to operational excellence.
The Agency strongly recommends applicants use these checklists while preparing their dossiers and before submitting their application.
In case of any questions, they should contact their procedure manager where appointed or send a query to the Agency via the pre-submission query service.
However, applicants using the checklists may still need to submit further information during the review of the submitted application if EMA identifies other issues that could impact the outcome of the validation/procedure. Applicants should always refer the relevant European Union legislation (see: Eudralex).
Improving the submission process
EMA monitors the quality of received applications in order to identify necessary process improvements, actions and updates to the published guidance documents.
The checklists are in line with the objectives agreed as part of the EU Medicines Agencies Network Strategy to 2020 .